DIFF Main Group
A61P 19/00 Drugs for skeletal disorders
Introduced: January 2000
IPC and CPC are identically structured here. All 4 subcodes exist in both systems.
IPC defines codes here since 2000.
Child Classifications
Navigate with arrow keys, Enter to open
- A61P 19/02 for joint disorders, e.g. arthritis, arthrosis since 2000 IPC+CPC Available in IPC and CPC
- A61P 19/04 for non-specific disorders of the connective tissue since 2000 IPC+CPC Available in IPC and CPC
- A61P 19/06 Antigout agents, e.g. antihyperuricemic or uricosuric agents since 2000 IPC+CPC Available in IPC and CPC
- A61P 19/08 for bone diseases, e.g. rachitism, Paget's disease since 2000 IPC+CPC Available in IPC and CPC
Top Applicants
Top Applicants (IPC)
Class A61,2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 18,523
- NOVARTIS CH 14,253
- COVIDIEN US 13,953
- ROCHE CH 12,005
- CHINESE ACADEMY OF SCIENCES 11,955
- UNIVERSITY OF CALIFORNIA US 11,692
- HARVARD UNIVERSITY US 11,596
- L'OREAL FR 11,593
- P&G (PROCTER & GAMBLE COMPANY) US 11,297
- OLYMPUS CORPORATION JP 9,594
Top Applicants (CPC)
Class A61,2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 20,621
- NOVARTIS CH 15,792
- ROCHE CH 14,303
- COVIDIEN US 13,862
- HARVARD UNIVERSITY US 13,454
- UNIVERSITY OF CALIFORNIA US 12,798
- P&G (PROCTER & GAMBLE COMPANY) US 12,140
- L'OREAL FR 11,800
- OLYMPUS CORPORATION JP 9,894
- BOSTON SCIENTIFIC SCIMED US 9,513